When should women get a dating ultrasound and first trimester bloodwork done by which week of gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of Dating Ultrasound and First Trimester Bloodwork in Pregnancy

Women should undergo dating ultrasound between 11-13+6 weeks gestation, with optimal timing at 11 completed weeks, and first trimester bloodwork should be completed during the same timeframe to maximize screening accuracy and clinical utility. 1

Dating Ultrasound Timing

First Trimester Dating (11-13+6 weeks)

  • First trimester ultrasound provides the most accurate pregnancy dating with a 95% confidence range of ±5 days 2
  • Crown-rump length (CRL) measurement between 45-84mm (corresponding to 11-13+6 weeks) is optimal for:
    • Accurate dating
    • Nuchal translucency (NT) measurement for aneuploidy screening
    • Determination of chorionicity in multiple gestations 3, 1
  • Earlier dating (before 11 weeks) may be performed but is less optimal for NT measurement 1

Benefits of First Trimester Dating

  • Confirms pregnancy viability
  • Establishes accurate gestational age for subsequent screening and management decisions
  • Identifies multiple gestations early
  • Allows for limited structural survey to detect major anomalies 4
  • Provides baseline for growth assessment in later pregnancy 5

First Trimester Bloodwork Timing

Optimal Timing (11-13+6 weeks)

  • First trimester aneuploidy screening should include:
    • Maternal serum pregnancy-associated plasma protein A (PAPP-A)
    • Free beta-hCG or total/intact hCG 1
  • These markers should be measured at the same time as NT ultrasound (11-13+6 weeks) for integrated risk assessment
  • Clinical sensitivity decreases after 13 completed weeks' gestation 1

Important Considerations

  • PAPP-A measurements are more discriminatory earlier in the first trimester 3
  • Ultrasound dating is strongly preferred over last menstrual period (LMP) dating for accurate interpretation of serum markers 3
  • Using LMP dating may result in inappropriately high screen-positive rates and is not recommended 3

Screening Options and Follow-Up

Integrated Screening

  • Full integrated test combines:
    • First trimester: NT measurement and PAPP-A
    • Second trimester: AFP, hCG, uE3, and inhibin-A 3
  • Provides highest detection rate (92% at 5% false-positive rate) 3

Sequential Screening

  • First trimester results categorized as:
    • High risk: Offered immediate diagnostic testing
    • Intermediate risk: Proceed to second trimester testing
    • Low risk: Reassurance provided 3

Second Trimester Follow-Up

  • Women should be offered MSAFP screening for neural tube defects at 16-18 weeks, even if they had first trimester screening 3
  • Multiple marker screening (quad screen) should be completed at 16-18 weeks unless amniocentesis is indicated or first trimester screening was performed 3

Common Pitfalls to Avoid

  1. Dating errors: Relying on LMP rather than ultrasound dating can lead to inaccurate risk assessment
  2. Missed timing window: Performing NT ultrasound after 13+6 weeks reduces screening accuracy
  3. Incomplete follow-up: Failing to complete second trimester screening for neural tube defects after first trimester screening
  4. Inadequate patient education: Not providing information about available screening options and their limitations

By adhering to the 11-13+6 week timeframe for both dating ultrasound and first trimester bloodwork, clinicians can optimize screening accuracy and provide women with the most reliable information for making informed decisions about their pregnancy care.

References

Guideline

Prenatal Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Dating and growth in the first trimester.

Best practice & research. Clinical obstetrics & gynaecology, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.